Study of Citicoline for the Treatment of Traumatic Brain Injury (COBRIT)
Public ClinicalTrials.gov record NCT00545662. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Citicoline Brain Injury Treatment Trial
Study identification
- NCT ID
- NCT00545662
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Enrollment
- 1,213 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- citicoline Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2007
- Primary completion
- Apr 30, 2011
- Completion
- Apr 30, 2011
- Last update posted
- Dec 18, 2012
2007 – 2011
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294-3295 | — |
| University of Maryland, Baltimore | Baltimore | Maryland | 21201 | — |
| Temple University | Philadelphia | Pennsylvania | 19141-3099 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213-3221 | — |
| University of Tennessee Health Sciences Center | Memphis | Tennessee | 38163 | — |
| University of Texas, Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298-0677 | — |
| University of Washington | Seattle | Washington | 23298-0631 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00545662, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00545662 live on ClinicalTrials.gov.